PL3952858T3 - Sposób leczenia guzów - Google Patents

Sposób leczenia guzów

Info

Publication number
PL3952858T3
PL3952858T3 PL20787143.5T PL20787143T PL3952858T3 PL 3952858 T3 PL3952858 T3 PL 3952858T3 PL 20787143 T PL20787143 T PL 20787143T PL 3952858 T3 PL3952858 T3 PL 3952858T3
Authority
PL
Poland
Prior art keywords
tumors
treatment
Prior art date
Application number
PL20787143.5T
Other languages
English (en)
Inventor
Victoria Anne Gordon
Paul Warren Reddell
Glen Mathew BOYLE
Jason Kingsley CULLEN
Peter Gordon Parsons
Original Assignee
QBiotics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019901280A external-priority patent/AU2019901280A0/en
Application filed by QBiotics Pty Ltd filed Critical QBiotics Pty Ltd
Publication of PL3952858T3 publication Critical patent/PL3952858T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20787143.5T 2019-04-12 2020-04-09 Sposób leczenia guzów PL3952858T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2019901280A AU2019901280A0 (en) 2019-04-12 Method of Treatment
PCT/AU2020/050360 WO2020206504A1 (en) 2019-04-12 2020-04-09 Method of treating tumours

Publications (1)

Publication Number Publication Date
PL3952858T3 true PL3952858T3 (pl) 2026-03-30

Family

ID=72752169

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20787143.5T PL3952858T3 (pl) 2019-04-12 2020-04-09 Sposób leczenia guzów

Country Status (26)

Country Link
US (1) US12226391B2 (pl)
EP (1) EP3952858B1 (pl)
JP (2) JP7900152B2 (pl)
KR (1) KR20210152531A (pl)
CN (1) CN113924091A (pl)
AU (1) AU2020256847B2 (pl)
BR (1) BR112021020253A2 (pl)
CA (1) CA3136216C (pl)
DK (1) DK3952858T3 (pl)
EA (1) EA202192757A1 (pl)
ES (1) ES3063750T3 (pl)
FI (1) FI3952858T3 (pl)
HR (1) HRP20260232T1 (pl)
IL (1) IL287210B2 (pl)
LT (1) LT3952858T (pl)
MX (1) MX2021012449A (pl)
MY (1) MY208979A (pl)
PL (1) PL3952858T3 (pl)
PT (1) PT3952858T (pl)
RS (1) RS67777B1 (pl)
SG (1) SG11202110599RA (pl)
SI (1) SI3952858T1 (pl)
SM (1) SMT202600066T1 (pl)
UA (1) UA129840C2 (pl)
WO (1) WO2020206504A1 (pl)
ZA (1) ZA202108677B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971588T3 (da) * 2005-12-23 2012-10-22 Qbiotics Ltd Tiglien-3-onderivater
JP7013753B2 (ja) * 2017-09-15 2022-02-01 株式会社三洋物産 遊技機
BR112021024716A2 (pt) 2019-06-19 2022-02-08 QBiotics Pty Ltd Ruptura de biofilme
CN118451065A (zh) * 2021-12-21 2024-08-06 Q生物股份有限公司 结晶中间体
EP4638430A4 (en) * 2022-12-21 2026-07-01 QBiotics Pty Ltd CRYSTALLINE FORMS AND THEIR PRODUCTION PROCESSES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971588T3 (da) * 2005-12-23 2012-10-22 Qbiotics Ltd Tiglien-3-onderivater
PT2986615T (pt) 2013-04-18 2019-03-22 Qbiotics Ltd Métodos e composições para a cicatrização de feridas
EP3490547A4 (en) * 2016-07-28 2020-04-01 QBiotics Pty Ltd TREATMENT METHOD
SG11201907891XA (en) * 2017-03-23 2019-09-27 QBiotics Pty Ltd Combination therapy for the treatment or prevention of tumours

Also Published As

Publication number Publication date
ZA202108677B (en) 2026-03-25
CA3136216A1 (en) 2020-10-15
SI3952858T1 (sl) 2026-04-30
WO2020206504A1 (en) 2020-10-15
AU2020256847A1 (en) 2021-11-11
IL287210B1 (en) 2025-03-01
UA129840C2 (uk) 2025-08-20
IL287210A (en) 2021-12-01
EA202192757A1 (ru) 2022-02-11
CN113924091A (zh) 2022-01-11
MY208979A (en) 2025-06-14
ES3063750T3 (en) 2026-04-20
FI3952858T3 (fi) 2026-02-18
US12226391B2 (en) 2025-02-18
RS67777B1 (sr) 2026-03-31
HRP20260232T1 (hr) 2026-03-27
SMT202600066T1 (it) 2026-03-09
LT3952858T (lt) 2026-04-10
US20220193023A1 (en) 2022-06-23
EP3952858A4 (en) 2022-05-25
SG11202110599RA (en) 2021-10-28
KR20210152531A (ko) 2021-12-15
EP3952858A1 (en) 2022-02-16
PT3952858T (pt) 2026-02-26
CA3136216C (en) 2024-01-16
AU2020256847B2 (en) 2025-05-15
MX2021012449A (es) 2021-11-12
IL287210B2 (en) 2025-07-01
EP3952858B1 (en) 2025-12-17
JP7900152B2 (ja) 2026-08-04
BR112021020253A2 (pt) 2021-12-07
JP2022528915A (ja) 2022-06-16
DK3952858T3 (da) 2026-02-23
JP2025060945A (ja) 2025-04-10

Similar Documents

Publication Publication Date Title
IL283838A (en) Method of treating cancer with a cancer therapy in combination with another therapeutic agent
IL282794A (en) Therapeutic methods
IL269026A (en) Methods of treating tumor
EP4017489C0 (en) DGD1202 FOR THE TREATMENT OF KRAS-MUTATED CANCERS
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
IL260443B (en) Anti-egfr combinations for treating tumors
PL3288581T3 (pl) Sposób leczenia nowotworu
EP3606962A4 (en) TREATMENT METHODS FOR HIGH CD73 TUMORS
IL272081A (en) Photodynamic therapy method for skin disorders
LT4034122T (lt) Hiperfenilalaninemijos gydymo būdai
EP4003994A4 (en) TREATMENT OF EVASIVE IMMUNE TUMORS
IL282311A (en) Use of reboxetine to treat narcolepsy
IL277981A (en) Cancer treatment methods
PT3952858T (pt) Método de tratamento de tumores
IL281600A (en) Methods of treating cancer
LT3576740T (lt) Vėžio gydymas
IL281845A (en) Combination therapy for the treatment of cancer
IL308399A (en) Methods of treating cancer
IL282041A (en) Egfr inhibitors for treating keratodermas
IL290983A (en) Treatment methods
EP3656854A4 (en) VIRUS FOR TREATMENT OF TUMORS
IL281839A (en) Treatment methods
IL281792A (en) Treatment methods
EP4025203A4 (en) CANCER TREATMENT
GB201820098D0 (en) Methods of cancer treatment